In BTBD2-BARD1, BARD1 was suggested as a mediator of apoptosis since its over-expression induces cell death [46]; and high LOH has been detected in human carcinoma metastases to the brain at chromosome 19p13.3 for BTBD2 [47]. Here, BTBD2 is linked to carcinoma.